Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredShares IssuedShares OutstandingShares Outstanding
Ratios

Fulcrum Therapeutics (FULC) Other Gross PP&E Adjustments (2018 - 2026)

Fulcrum Therapeutics (FULC) has 9 years of Other Gross PP&E Adjustments data on record, last reported at $13.0 million in Q1 2026.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 5.19% to $13.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $13.0 million, a 5.19% increase, with the full-year FY2025 number at $13.5 million, up 14.82% from a year prior.
  • Other Gross PP&E Adjustments reached $13.0 million in Q1 2026 per FULC's latest filing, down from $13.5 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for FULC hit a ceiling of $13.5 million in Q4 2025 and a floor of $5.3 million in Q1 2022.
  • A 5-year average of $10.3 million and a median of $10.8 million in 2024 define the central range for Other Gross PP&E Adjustments.
  • Peak YoY movement for Other Gross PP&E Adjustments: plummeted 62.88% in 2022, then surged 61.5% in 2023.
  • Tracing FULC's Other Gross PP&E Adjustments over 5 years: stood at $8.0 million in 2022, then grew by 29.81% to $10.3 million in 2023, then grew by 13.97% to $11.8 million in 2024, then grew by 14.82% to $13.5 million in 2025, then fell by 3.92% to $13.0 million in 2026.
  • Business Quant data shows Other Gross PP&E Adjustments for FULC at $13.0 million in Q1 2026, $13.5 million in Q4 2025, and $13.4 million in Q3 2025.